Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients
- MENU
- ABOUT
Overview
Annual Report
Governance
- Bylaws
- Leadership
- Board of Directors
- Nomination Process
- Organizational Structure
- ATS Policies
- ATS Website
- MyATS Tutorial
Newsroom
ATS Awards
ATS Social Media
ATS Videos
Breathe Easy Podcasts
Ethics & COI
Health Equity
Industry Resources
- Value of Collaboration
- Corporate Members
- Advertising Opportunities
- Clinical Trials
- Financial Disclosure
In Memoriam
Global Health
- International Trainee Scholarships (ITS)
- MECOR Program
- Forum of International Respiratory Societies (FIRS)
- Resources
Membership
Chapters
Peer Organizations
Careers at ATS
Staff
Contact Us
SITEMAP - ADVOCACY
- PROFESSIONALS
Career Development
- Resident & Medical Students
- Fellows
- Junior Faculty
- Training Program Directors
- ATS Reading List
- ATS Scholarships
- ATS Virtual Network
Education
ATS Podcasts
ATS Webinars
Best of ATS Video Lecture Series
Professional Accreditation
Pulmonary Function Testing (PFT)
Calendar of Events
Ethics & COI
Job Board
APCCSD
SITEMAP - PATIENTS
- MEMBERS
Assemblies & Sections
- About
- Assemblies
- Sections
- FAQ
- Abstract Scholarships
- ATS Mentoring Programs
- ATS Official Documents
- ATS Interest Groups
Sections
Assemblies
- Allergy, Immunology & Inflammation
- Behavioral Science and Health Services Research
- Clinical Problems
- Critical Care
- Environmental, Occupational & Population Health
- Nursing
- Pediatrics
- Pulmonary Circulation
- Pulmonary Infections and Tuberculosis
- Pulmonary Rehabilitation
- Respiratory Cell & Molecular Biology
- Respiratory Structure & Function
- Sleep & Respiratory Neurobiology
- Thoracic Oncology
Committees
- Awards
- Joint ATS/CHEST Clinical Practice Committee
- Council of Chapter Representatives
- Documents Development and Implementation
- Drug/Device Discovery and Development
- Education
- Environmental Health Policy
- Ethics and Conflict of Interest
- Finance
- Health Equity and Diversity Committee
- Health Policy
- International Conference Committee
- International Health
- View more...
Membership
- Membership Benefits
- Categories & Fees
- Special Membership Programs
- Renew Your Membership
- Update Your Profile
- ATS DocMatter Community
- Respiratory Medicine Book Series
- ATS Fellow
- Elizabeth A. Rich, MD Award
- Member Directory
- ATS Career Center
- Welcome Trainees
- ATS Wellness
Member Newsletters
Chapters
Corporate Membership
SITEMAP
Journal Club
Home ▶
Professionals ▶
Clinical Resources ▶
Critical Care ▶
Journal Club ▶
Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients
Cost-effectiveness of Dalteparin vs Unfractionated Heparin for the Prevention of Venous Thromboembolism in Critically Ill Patients
The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.
AMERICAN THORACIC SOCIETY
25 Broadway
New York, NY 10004
United States of America
Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: atsinfo@thoracic.org
© 1998 - American Thoracic Society, all rights reserved.
